Summit Therapeutics Inc. Annual Nonoperating Income (Expense) in USD from 2018 to 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Summit Therapeutics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2018 to 2024.
  • Summit Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2025 was $2.73M, a 16.9% increase year-over-year.
  • Summit Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2025 was $15.7M, a 20.5% decline year-over-year.
  • Summit Therapeutics Inc. annual Nonoperating Income (Expense) for 2024 was $13.4M, a 19.5% increase from 2023.
  • Summit Therapeutics Inc. annual Nonoperating Income (Expense) for 2023 was $11.2M.
  • Summit Therapeutics Inc. annual Nonoperating Income (Expense) for 2022 was -$2.29M, a 5.13% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $13.4M +$2.19M +19.5% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-24
2023 $11.2M +$13.5M Jan 1, 2023 Dec 31, 2023 10-K 2025-02-24
2022 -$2.29M +$124K +5.13% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-24
2021 -$2.42M -$2.7M -954% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $283K +$1.9M Jan 1, 2020 Dec 31, 2020 10-K/A 2022-12-21
2019 -$1.62M -$5.31M -144% Feb 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $3.69M Feb 1, 2018 Jan 31, 2019 10-K 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.